MTVA (MetaVia) Cyclically Adjusted FCF per Share: $-57,621.42 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTVA MetaVia Inc MTVA
28 GF Score
Price $1.55
! 1 Warning Sign
View Full Analysis

What is MetaVia Cyclically Adjusted FCF per Share?

MetaVia MTVA -3.44% 28 Cyclically Adjusted FCF per Share is $-57,621.42 as of Jun. 2026. GuruFocus rates MTVA with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MetaVia's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-57,621.42 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-16), MetaVia's current stock price is $1.545. MetaVia's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $-57,621.42. MetaVia's Cyclically Adjusted Price-to-FCF of today is .


MetaVia  (NAS:MTVA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MetaVia Cyclically Adjusted FCF per Share Related Terms


MetaVia Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for MetaVia's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaVia Cyclically Adjusted FCF per Share Chart

MetaVia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -55,789.00 -57,039.29 -41,479.68

MetaVia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58,296.45 -58,701.10 -60,827.58 -59,865.15 -57,621.42

MTVA vs VTGN, TOVX, GDTC: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, MetaVia's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetaVia Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaVia's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MetaVia's Cyclically Adjusted Price-to-FCF falls into.


MTVA
28GF Score
MetaVia Inc MTVA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetaVia Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MetaVia's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

MetaVia Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -34,343.561 241.428 -47,505.264
201612 -25,811.528 241.432 -35,702.854
201703 -43,137.101 243.801 -59,088.031
201706 -41,199.538 244.955 -56,168.146
201709 -45,345.642 246.819 -61,353.736
201712 -41,959.770 246.524 -56,840.507
201803 -38,391.616 249.554 -51,375.482
201806 -29,113.187 251.989 -38,582.664
201809 -19,874.484 252.439 -26,291.990
201812 -19,029.105 251.233 -25,294.478
201903 -15,635.173 254.202 -20,540.347
201906 -15,545.756 256.143 -20,268.117
201909 -43,916.442 256.759 -57,119.648
201912 -72.465 256.974 -94.172
202003 -697.450 258.115 -902.368
202006 -376.317 257.797 -487.484
202009 -314.023 260.280 -402.907
202012 -315.385 260.474 -404.353
202103 -750.024 264.877 -945.616
202106 -426.917 271.696 -524.740
202109 -296.986 274.310 -361.558
202112 -287.054 278.802 -343.836
202203 -478.159 287.504 -555.408
202206 -269.032 296.311 -303.208
202209 -233.592 296.808 -262.825
202212 -6.252 296.797 -7.035
202303 -5.547 301.836 -6.137
202306 -4.447 305.109 -4.867
202309 -6.179 307.789 -6.704
202312 -7.367 306.746 -8.020
202403 -13.934 312.332 -14.899
202406 -14.698 314.175 -15.623
202409 -6.019 315.301 -6.375
202412 -6.913 315.605 -7.315
202503 -5.160 319.799 -5.388
202506 -2.211 322.561 -2.289
202509 -1.331 324.800 -1.369
202512 -2.105 324.054 -2.169
202603 -0.876 330.213 -0.886
202606 0.000 333.952 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-57,621.42 mean?
MetaVia (MTVA) has a Cyclically Adjusted FCF per Share of $-57,621.42 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MetaVia and its competitors.
Is MetaVia's Cyclically Adjusted FCF per Share too high?
MetaVia's current Cyclically Adjusted FCF per Share is $-57,621.42. Overall, MetaVia has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does MetaVia's Cyclically Adjusted FCF per Share compare to VTGN and TOVX?
MetaVia's Cyclically Adjusted FCF per Share of $-57,621.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MetaVia and its competitors. MetaVia's current Cyclically Adjusted FCF per Share is $-57,621.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaVia stock overvalued right now?
MetaVia (MTVA) has a current Cyclically Adjusted FCF per Share of $-57,621.42. The current Cyclically Adjusted FCF per Share is $-57,621.42. MetaVia's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For MetaVia (MTVA), the current Cyclically Adjusted FCF per Share is $-57,621.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaVia Business Description

Address 545 Concord Avenue, Suite 210, Cambridge, MA, USA, 02138
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
28GF Score

Get the complete analysis for MTVA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.55
Price